Search for safer and potent natural inhibitors of Parkinson's disease

This publication has 63 references indexed in Scilit:

• Executive dysfunction in P arkinson's disease: A review
  Journal of Neuropsychology, 2013
• Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
  Neuropsychopharmacology, 2011
• Virtual Reality for Gait Training: Can It Induce Motor Learning to Enhance Complex Walking and Reduce Fall Risk in Patients With Parkinson's Disease?
  The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
• Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis
  Journal of Epidemiology and Community Health, 2009
• Pharmacokinetics and pharmacodynamics of levodopa
  Movement Disorders, 2008
• Optimizing Long-Term Therapy for Parkinson Disease
  Clinical Neuropharmacology, 2008
• D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons
  Trends in Neurosciences, 2007
• Current Pharmacotherapeutic Treatment Options in Parkinson’s Disease
  Disease-a-Month, 2007
• Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
  Journal of Neurology, Neurosurgery & Psychiatry, 2004
• The substantia nigra of the human brain
  Brain, 1999